Serena Lucotti
Serena Lucotti
Postdoctoral Associate, Weill Cornell Medical College
Verified email at
Cited by
Cited by
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
Coagulation and metastasis: what does the experimental literature tell us?
AM Gil‐Bernabé, S Lucotti, RJ Muschel
British journal of haematology 162 (4), 433-441, 2013
Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
S Lucotti, C Cerutti, M Soyer, AM Gil-Bernabé, AL Gomes, PD Allen, ...
The Journal of clinical investigation 129 (5), 1845-1862, 2019
Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival
S Lucotti, G Rainaldi, M Evangelista, M Rizzo
Molecular cancer 12 (1), 1-10, 2013
Tumour-Derived Laminin α5 (LAMA5) Promotes Colorectal Liver Metastasis Growth, Branching Angiogenesis and Notch Pathway Inhibition
A Gordon-Weeks, SY Lim, A Yuzhalin, S Lucotti, JAF Vermeer, K Jones, ...
Cancers 11 (5), 630, 2019
Platelets and metastasis: new implications of an old interplay
S Lucotti, RJ Muschel
Frontiers in Oncology 10, 1350, 2020
Cell-free DNA (cfDNA) and exosome profiling from a year-long human spaceflight reveals circulating biomarkers
D Bezdan, K Grigorev, C Meydan, FAP Vatter, M Cioffi, V Rao, M MacKay, ...
IScience 23 (12), 101844, 2020
Radiation resistant cancer cells enhance the survival and resistance of sensitive cells in prostate spheroids
P Kannan, M Paczkowski, A Miar, J Owen, WW Kretzschmar, S Lucotti, ...
bioRxiv, 564724, 2019
The RNA activator ds-p21 potentiates the cytotoxicity induced by fludarabine in Dohh2 cells
F Patella, S Lucotti, M Rizzo, M Evangelista, G Rainaldi
Oligonucleotides 21 (1), 39-45, 2011
Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function
FAP Vatter, S Lucotti, H Zhang
Journal of Mammary Gland Biology and Neoplasia, 1-13, 2020
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings
RE Shor, J Dai, SY Lee, L Pisarsky, I Matei, S Lucotti, D Lyden, MJ Bissell, ...
Molecular Oncology, 2021
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids
L Bojmar, HS Kim, GC Tobias, FAP Vatter, S Lucotti, KE Gyan, CM Kenific, ...
STAR protocols 2 (1), 100225, 2021
The system can't perform the operation now. Try again later.
Articles 1–12